DNA Script to Present Key Technology Milestone at SynBioBeta 2018: The Global Synthetic Biology Summit

Paris, France, September 27th 2018 - DNA Script, the leader in enzymatic de novo DNA synthesis, is set to announce the most advanced technological milestone to date for the field, in a talk given by Thomas Ybert, chief executive officer, at SynBioBeta 2018: The Global Synthetic Biology Summit on Tuesday, October 2 at 1:40 p.m. PDT in San Francisco.

The talk, entitled 'Leaping Ahead of Chemistry - The Path Forward for Enzymatic DNA Synthesis', will feature world-premiere results.

For more information on SynBioBeta 2018: The Global Synthetic Biology Summit, please visit: https://2018.synbiobeta.com/

About DNA Script
Founded in 2014 in Paris, DNA Script is the world's leading company in manufacturing de novo synthetic nucleic acids using an enzymatic technology. The company aims to accelerate innovation in life sciences and technology through rapid, affordable and high-quality DNA synthesis. DNA Script's approach leverages billions of years of natural evolution to enable genome-scale synthesis. The company's technology has the potential to greatly accelerate the development of new therapeutics, sustainable chemical production, improved crops and DNA data storage.
www.dnascript.co

Press contact in the US
Seismic
Eric Schubert
415-939-4366
eric@teamseismic.com

Press contacts in Europe
ALIZE RP
Caroline Carmagnol and Tatiana Vieira
+33 6 64 18 99 59 / +33 1 44 54 36 65
DNASCRIPT@alizerp.com

DNA Script Contact
Sylvain Gariel, COO
sg@dnascript.co